isatin has been researched along with Idiopathic Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Hitge, R; Petzer, A; Petzer, JP | 1 |
| Glover, V; Sandler, M; Stern, GM; Stibbe, K; Ueki, A; Willoughby, J | 1 |
| Abdelgawad, MA; Almohaimeed, HM; Benny, F; El-Sherbiny, M; Gahtori, P; Ghoneim, MM; Kim, H; Kumar, S; Manoharan, A; Mathew, B; Oh, JM; Shaker, ME | 1 |
| Endo, T; Hamaue, N; Hirafuji, M; Hiroshige, T; Machida, M; Minami, M; Ogata, A; Parvez, SH; Saito, H; Tashiro, K; Terado, M | 1 |
| Glover, V; Igosheva, N; Lorz, C; Mehmet, H; O'Conner, E | 1 |
| Hamaue, N; Hirafuji, M; Hiroshige, T; Minami, M; Ogata, A; Parvez, SH; Saito, H; Tashiro, K | 1 |
| Clow, A; Glover, V; Sandler, M | 1 |
| Endo, T; Hamaue, N; Hirafuji, M; Ide, H; Minami, M; Ogata, A; Tashiro, K; Terado, M; Yamazaki, N; Yoshioka, M | 1 |
| Hamaue, N | 1 |
2 review(s) available for isatin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
Topics: Aging; Animals; Corpus Striatum; Enzyme Induction; Free Radicals; Humans; Isatin; Life Expectancy; Nerve Degeneration; Parkinson Disease; Pergolide; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase | 1993 |
[Pharmacological role of isatin, an endogenous MAO inhibitor].
Topics: Acetylcholine; Animals; Anxiety; Behavior, Animal; Biomarkers; Blood Pressure; Brain; Dopamine; Humans; Isatin; Monoamine Oxidase Inhibitors; Norepinephrine; Parkinson Disease; Rats; Serotonin | 2000 |
7 other study(ies) available for isatin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones.
Topics: Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Structure-Activity Relationship | 2022 |
Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson's disease and other neurological disorders.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Female; Humans; Isatin; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nervous System Diseases; Parkinson Disease | 1989 |
Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Topics: Antipsychotic Agents; Dopamine Agents; Humans; Isatin; Microwaves; Molecular Docking Simulation; Monoamine Oxidase; Neuroblastoma; Pargyline; Parkinson Disease; Pharmacophore | 2023 |
Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Topics: Animals; Disease Models, Animal; Dopamine; Encephalitis Virus, Japanese; Hypokinesia; Isatin; Mice; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats; Selegiline | 2004 |
Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
Topics: Annexin A5; Antiparkinson Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isatin; Monoamine Oxidase Inhibitors; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Parkinson Disease; Propidium; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Encephalitis Virus, Japanese; Isatin; Monoamine Oxidase Inhibitors; Motor Activity; Parkinson Disease; Rats; Tyrosine 3-Monooxygenase | 2006 |
[Effects of isatin, an endogenous MAO inhibitor, on dopamine (DA) and acetylcholine (ACh) concentrations in rats].
Topics: Acetylcholine; Animals; Brain Chemistry; Disease Models, Animal; Dopamine; Humans; Isatin; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats; Rats, Inbred F344; Rats, Inbred SHR; Rats, Inbred WKY | 1999 |